Variant report

Variant	nsv52528
Chromosome Location	chr12:25204785-25213609
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:379)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:379 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr12:25210641-25210775	K562	blood:	n/a	n/a
2	ATF1	chr12:25208908-25208952	K562	blood:	n/a	n/a
3	ATF1	chr12:25205322-25205827	K562	blood:	n/a	n/a
4	ATF2	chr12:25207368-25208336	GM12878	blood:	n/a	n/a
5	ATF2	chr12:25204201-25206192	GM12878	blood:	n/a	n/a
6	ATF2	chr12:25207527-25208150	GM12878	blood:	n/a	n/a
7	ATF2	chr12:25204452-25205709	GM12878	blood:	n/a	n/a
8	BATF	chr12:25211455-25211794	GM12878	blood:	n/a	n/a
9	BATF	chr12:25207646-25208201	GM12878	blood:	n/a	chr12:25207929-25207940 chr12:25207914-25207925
10	BATF	chr12:25207695-25208119	GM12878	blood:	n/a	chr12:25207929-25207940 chr12:25207914-25207925
11	BATF	chr12:25204960-25205605	GM12878	blood:	n/a	n/a
12	BATF	chr12:25211463-25212037	GM12878	blood:	n/a	n/a
13	BCL11A	chr12:25211434-25211849	GM12878	blood:	n/a	chr12:25211581-25211590
14	BCL11A	chr12:25207637-25208123	GM12878	blood:	n/a	n/a
15	BCL11A	chr12:25204664-25205633	GM12878	blood:	n/a	n/a
16	BCL11A	chr12:25207711-25208061	GM12878	blood:	n/a	n/a
17	BCL3	chr12:25207661-25208078	GM12878	blood:	n/a	n/a
18	BCLAF1	chr12:25211529-25212216	GM12878	blood:	n/a	chr12:25211581-25211590
19	BCLAF1	chr12:25204434-25206103	GM12878	blood:	n/a	chr12:25205721-25205730
20	BCLAF1	chr12:25207238-25208275	GM12878	blood:	n/a	n/a
21	BCLAF1	chr12:25208624-25209275	GM12878	blood:	n/a	n/a
22	BHLHE40	chr12:25207700-25208085	GM12878	blood:	n/a	n/a
23	BHLHE40	chr12:25205406-25205740	K562	blood:	n/a	n/a
24	BHLHE40	chr12:25204512-25204848	HepG2	liver:	n/a	n/a
25	BHLHE40	chr12:25204189-25205783	GM12878	blood:	n/a	n/a
26	BHLHE40	chr12:25204352-25204928	K562	blood:	n/a	n/a
27	CEBPB	chr12:25204554-25205873	GM12878	blood:	n/a	n/a
28	CEBPB	chr12:25207697-25208015	GM12878	blood:	n/a	n/a
29	CEBPB	chr12:25210658-25210762	K562	blood:	n/a	n/a
30	CEBPB	chr12:25207577-25208260	GM12878	blood:	n/a	n/a
31	CHD1	chr12:25210594-25212152	GM12878	blood:	n/a	n/a
32	CHD1	chr12:25213025-25213461	GM12878	blood:	n/a	n/a
33	CHD1	chr12:25204001-25206646	GM12878	blood:	n/a	n/a
34	CHD1	chr12:25208802-25210220	GM12878	blood:	n/a	n/a
35	CHD1	chr12:25206955-25208409	GM12878	blood:	n/a	n/a
36	CHD2	chr12:25204205-25205838	GM12878	blood:	n/a	n/a
37	CHD2	chr12:25207563-25208067	GM12878	blood:	n/a	n/a
38	CREB1	chr12:25204405-25206093	GM12878	blood:	n/a	n/a
39	CREB1	chr12:25204415-25205814	GM12878	blood:	n/a	n/a
40	CREB1	chr12:25207593-25208204	GM12878	blood:	n/a	n/a
41	CTCF	chr12:25205145-25205345	K562	blood:	n/a	n/a
42	CTCF	chr12:25205520-25205670	GM12872	blood:	n/a	n/a
43	CTCF	chr12:25205400-25205550	SAEC	small airway:	n/a	n/a
44	CTCF	chr12:25209880-25210030	GM12873	blood:	n/a	n/a
45	CTCF	chr12:25205820-25205970	AoAF	blood vessel:	n/a	n/a
46	CTCF	chr12:25205360-25205510	GM12864	blood:	n/a	n/a
47	CTCF	chr12:25205440-25205590	NB4	blood:	n/a	n/a
48	CTCF	chr12:25205800-25205950	Caco-2	colon:	n/a	n/a
49	CTCF	chr12:25209901-25209970	GM19239	blood:	n/a	n/a
50	CTCF	chr12:25205380-25205530	GM12873	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:25205468-25205518	AoSMC	blood vessel:	n/a
2	chr12:25205468-25205518	HEK293	kidney:	embryo
3	chr12:25205468-25205518	ProgFib	skin:	n/a
4	chr12:25205468-25205518	HIPEpiC	eye:	n/a
5	chr12:25205468-25205518	HCF	heart:	n/a
6	chr12:25205468-25205518	HPAEpiC	pulmonary alveolar:	n/a
7	chr12:25205468-25205518	NHBE	bronchial:	n/a
8	chr12:25205468-25205518	HAEpiC	amniotic membrane:	n/a
9	chr12:25205468-25205518	SK-N-SH	brain:	n/a
10	chr12:25205468-25205518	U87	brain:	n/a
11	chr12:25205468-25205518	BE2_C	brain:	n/a
12	chr12:25205468-25205518	H1-hESC	embryonic stem cell:	embryo
13	chr12:25205468-25205518	SK-N-MC	brain:	n/a
14	chr12:25205468-25205518	SK-N-SH_RA	brain:	n/a
15	chr12:25205468-25205518	GM12878	blood:	n/a
16	chr12:25205468-25205518	HL-60	blood:	n/a
17	chr12:25205468-25205518	Hela-S3	cervix:	n/a
18	chr12:25205468-25205518	HMEC	breast:	n/a
19	chr12:25205468-25205518	Hepatocyte	liver:	n/a
20	chr12:25205468-25205518	A549	lung:	n/a
21	chr12:25205468-25205518	K562	blood:	n/a
22	chr12:25205468-25205518	GM19239	blood:	n/a
23	chr12:25205468-25205518	GM12892	blood:	n/a
24	chr12:25205468-25205518	HRCEpiC	kidney:	n/a
25	chr12:25205468-25205518	AG04449	skin:	fetal
26	chr12:25205468-25205518	PrEC	prostate:	n/a
27	chr12:25205468-25205518	NT2-D1	testis:	n/a
28	chr12:25205468-25205518	AG04450	lung:	fetal
29	chr12:25205468-25205518	HRPEpiC	eye:	n/a
30	chr12:25205468-25205518	IMR90	lung:	fetal
31	chr12:25205468-25205518	NHDF-neo	bronchial:	n/a
32	chr12:25205468-25205518	T-47D	breast:	n/a
33	chr12:25205468-25205518	AG09309	skin:	n/a
34	chr12:25205468-25205518	HCM	heart:	n/a
35	chr12:25205468-25205518	AG10803	skin:	n/a
36	chr12:25205468-25205518	HUVEC	blood vessel:	n/a
37	chr12:25205468-25205518	MCF-7	breast:	n/a
38	chr12:25205468-25205518	HNPCEpiC	eye:	n/a
39	chr12:25205468-25205518	ovcar-3	ovarian:	n/a
40	chr12:25205468-25205518	PANC-1	pancreas:	n/a
41	chr12:25205468-25205518	NB4	blood:	n/a
42	chr12:25205468-25205518	HRE	kidney:	n/a
43	chr12:25205468-25205518	PFSK-1	brain:	n/a
44	chr12:25205468-25205518	ECC-1	luminal epithelium:	n/a
45	chr12:25205468-25205518	AG09319	gingival:	n/a
46	chr12:25205468-25205518	LNCaP	prostate:	n/a
47	chr12:25205468-25205518	CMK	blood:	n/a
48	chr12:25205468-25205518	GM12891	blood:	n/a
49	chr12:25205468-25205518	HCT-116	colon:	n/a
50	chr12:25205468-25205518	BJ	skin:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:25204124..25204859-chr19:5686900..5687423,2	NB4	blood:
2	chr12:25209282..25211076-chr12:25214463..25216307,2	K562	blood:

No data

Variant related genes	Relation type
LRMP	TF binding region
LRMP	CpG island
ENSG00000167733	chromatin interactions

Extended variants
information (count: 384 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:384 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs538301308	chr12:25204812-25204813	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs550128639	chr12:25204919-25204920	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs73075637	chr12:25204930-25204931	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs538832054	chr12:25204935-25204936	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs193254705	chr12:25205024-25205025	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs572405642	chr12:25205066-25205067	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs572400166	chr12:25205094-25205095	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs74386676	chr12:25205129-25205130	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs555301446	chr12:25205130-25205131	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs11436031	chr12:25205138-25205139	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs66466831	chr12:25205139-25205140	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs10690368	chr12:25205160-25205161	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs573677348	chr12:25205181-25205182	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs2086939	chr12:25205241-25205242	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs1318731	chr12:25205248-25205249	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs562556963	chr12:25205317-25205318	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs577955290	chr12:25205360-25205361	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs73282853	chr12:25205380-25205381	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs545220735	chr12:25205384-25205385	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs75331070	chr12:25205391-25205392	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs560466550	chr12:25205396-25205397	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs374044308	chr12:25205410-25205411	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs185732658	chr12:25205415-25205416	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs542267928	chr12:25205422-25205423	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs141639356	chr12:25205427-25205428	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs190594410	chr12:25205452-25205453	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs562360480	chr12:25205453-25205454	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs113111522	chr12:25205462-25205463	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs181008530	chr12:25205469-25205470	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs183559413	chr12:25205532-25205533	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs76640161	chr12:25205541-25205542	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs566542947	chr12:25205560-25205561	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs532611732	chr12:25205562-25205563	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs188628390	chr12:25205564-25205565	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs566041081	chr12:25205576-25205577	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs11537537	chr12:25205607-25205608	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs536925476	chr12:25205677-25205678	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs533965194	chr12:25205688-25205689	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs1497258	chr12:25205721-25205722	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs181057183	chr12:25205735-25205736	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs537436570	chr12:25205737-25205738	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs185879688	chr12:25205752-25205753	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs577765861	chr12:25205793-25205794	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs2291366	chr12:25205801-25205802	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs553976881	chr12:25205816-25205817	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs572270901	chr12:25205833-25205834	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs533591990	chr12:25205839-25205840	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs376900506	chr12:25205871-25205872	Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs542934572	chr12:25205904-25205905	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs561008899	chr12:25205909-25205910	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Malignant germ cell tumour	17285132	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	17133270	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	16397240	CNVD
Neurodevelopmental disorder	22521361	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	21509527	CNVD
Autism	22102821	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	18438408	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22048815	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Heart disease	21282601	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	17925434	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Gastric cancer	24379144	CNVD
Gastric cancer	19545448	CNVD
Lung cancer	20031968	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung adenocarcinoma	19826477	CNVD
Lung cancer	19525976	CNVD
Lung cancer	19826477	CNVD
Non-small cell lung cancer	19451690	CNVD
Non-small cell lung cancer	17504988	CNVD
Bipolar disorder	19114987	CNVD
Lung cancer	19671679	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Lung adenocarcinoma	17982442	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17699850	CNVD
Ovarian cancer	17699850	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	20164920	CNVD

Chromatin state (count:383 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:25200400-25205000	Weak transcription	Liver	Liver
2	chr12:25202800-25205600	Weak transcription	Stomach Mucosa	stomach
3	chr12:25203800-25204800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
4	chr12:25203800-25204800	Flanking Active TSS	GM12878-XiMat	blood
5	chr12:25203800-25205000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
6	chr12:25203800-25205000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr12:25203800-25205000	Flanking Active TSS	Dnd41	blood
8	chr12:25203800-25205200	Flanking Active TSS	Primary B cells from cord blood	blood
9	chr12:25204000-25204800	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
10	chr12:25204000-25205000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
11	chr12:25204000-25208400	Flanking Active TSS	Primary hematopoietic stem cells	blood
12	chr12:25204200-25204800	Flanking Active TSS	Primary T cells fromperipheralblood	blood
13	chr12:25204200-25204800	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
14	chr12:25204200-25204800	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
15	chr12:25204200-25204800	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
16	chr12:25204200-25204800	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
17	chr12:25204200-25204800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
18	chr12:25204200-25204800	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
19	chr12:25204200-25205000	Flanking Active TSS	Primary B cells from peripheral blood	blood
20	chr12:25204200-25205000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
21	chr12:25204200-25205000	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
22	chr12:25204200-25205000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
23	chr12:25204200-25205000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr12:25204200-25205200	Flanking Active TSS	Primary T cells from cord blood	blood
25	chr12:25204200-25205200	Enhancers	K562	blood
26	chr12:25204200-25205400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
27	chr12:25204200-25205400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr12:25204200-25205400	Enhancers	Pancreas	Pancrea
29	chr12:25204200-25205600	Bivalent Enhancer	HepG2	liver
30	chr12:25204200-25206200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
31	chr12:25204200-25208000	Active TSS	Rectal Smooth Muscle	rectum
32	chr12:25204400-25204800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
33	chr12:25204400-25204800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr12:25204400-25204800	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood
35	chr12:25204400-25205000	Weak transcription	Fetal Lung	lung
36	chr12:25204400-25205200	Enhancers	Fetal Intestine Large	intestine
37	chr12:25204400-25205400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
38	chr12:25204400-25205800	Enhancers	iPS-15b Cell Line	embryonic stem cell
39	chr12:25204400-25208200	Active TSS	Adipose Nuclei	Adipose
40	chr12:25204400-25209200	Active TSS	Duodenum Mucosa	Duodenum
41	chr12:25204400-25210200	Active TSS	Rectal Mucosa Donor 29	rectum
42	chr12:25204600-25204800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr12:25204600-25204800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr12:25204600-25204800	Active TSS	Fetal Thymus	thymus
45	chr12:25204600-25204800	Flanking Active TSS	Thymus	Thymus
46	chr12:25204600-25205200	Weak transcription	Fetal Intestine Small	intestine
47	chr12:25204800-25205000	Flanking Active TSS	Fetal Thymus	thymus
48	chr12:25204800-25205000	Enhancers	Spleen	Spleen
49	chr12:25204800-25205200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
50	chr12:25204800-25205400	Active TSS	Primary mononuclear cells fromperipheralblood	Blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links